National Cancer Center Hospital

Chūōku, Tokyo-To 104-0045

1 studies enrolling now · 4 studies all time

What they study most

Advanced or Metastatic Gastric or Gastroesophageal Cancer, Advanced or Metastatic Solid Tumor, Breast Cancer, First Line Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Myeloid or Lymphoid Neoplasms (MLN)

Studies at this site

• A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03) — Recruiting now
• DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02] — Completed
• Futibatinib in Patients With Specific FGFR Aberrations — Stopped early
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed